DANONE (BN.PA)

FR0000120644 - Common Stock

59.6  -0.34 (-0.57%)

Fundamental Rating

4

Taking everything into account, BN scores 4 out of 10 in our fundamental rating. BN was compared to 59 industry peers in the Food Products industry. BN has a medium profitability rating, but doesn't score so well on its financial health evaluation. BN is not valued too expensively and it also shows a decent growth rate.



6

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
In the past year BN had a positive cash flow from operations.
In the past 5 years BN has always been profitable.
BN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

BN has a Return On Assets (1.96%) which is in line with its industry peers.
BN has a Return On Equity (5.40%) which is in line with its industry peers.
BN's Return On Invested Capital of 5.81% is fine compared to the rest of the industry. BN outperforms 62.07% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BN is in line with the industry average of 6.07%.
The last Return On Invested Capital (5.81%) for BN is above the 3 year average (5.56%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.96%
ROE 5.4%
ROIC 5.81%
ROA(3y)2.74%
ROA(5y)3.4%
ROE(3y)7.22%
ROE(5y)8.95%
ROIC(3y)5.56%
ROIC(5y)5.64%

1.3 Margins

Looking at the Profit Margin, with a value of 3.16%, BN is in line with its industry, outperforming 58.62% of the companies in the same industry.
In the last couple of years the Profit Margin of BN has declined.
BN has a Operating Margin of 12.60%. This is amongst the best in the industry. BN outperforms 82.76% of its industry peers.
BN's Operating Margin has declined in the last couple of years.
The Gross Margin of BN (47.37%) is better than 79.31% of its industry peers.
BN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.6%
PM (TTM) 3.16%
GM 47.37%
OM growth 3Y-3.56%
OM growth 5Y-2.72%
PM growth 3Y-27.27%
PM growth 5Y-19.71%
GM growth 3Y-0.48%
GM growth 5Y-0.41%

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BN is still creating some value.
The number of shares outstanding for BN has been increased compared to 1 year ago.
BN has less shares outstanding than it did 5 years ago.
BN has a worse debt/assets ratio than last year.

2.2 Solvency

BN has an Altman-Z score of 2.18. This is not the best score and indicates that BN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.18, BN perfoms like the industry average, outperforming 51.72% of the companies in the same industry.
The Debt to FCF ratio of BN is 6.01, which is on the high side as it means it would take BN, 6.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BN (6.01) is better than 65.52% of its industry peers.
A Debt/Equity ratio of 0.82 indicates that BN is somewhat dependend on debt financing.
BN's Debt to Equity ratio of 0.82 is on the low side compared to the rest of the industry. BN is outperformed by 63.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 6.01
Altman-Z 2.18
ROIC/WACC1.04
WACC5.58%

2.3 Liquidity

A Current Ratio of 0.93 indicates that BN may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.93, BN is doing worse than 82.76% of the companies in the same industry.
BN has a Quick Ratio of 0.93. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN's Quick ratio of 0.76 is in line compared to the rest of the industry. BN outperforms 44.83% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.76

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.21% over the past year.
The Earnings Per Share has been decreasing by -0.22% on average over the past years.
Looking at the last year, BN shows a decrease in Revenue. The Revenue has decreased by -0.15% in the last year.
BN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.30% yearly.
EPS 1Y (TTM)3.21%
EPS 3Y1.96%
EPS 5Y-0.22%
EPS growth Q2Q-1.11%
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y5.35%
Revenue growth 5Y2.3%
Revenue growth Q2Q-6.17%

3.2 Future

The Earnings Per Share is expected to grow by 6.49% on average over the next years.
Based on estimates for the next years, BN will show a small growth in Revenue. The Revenue will grow by 3.39% on average per year.
EPS Next Y3.61%
EPS Next 2Y5.68%
EPS Next 3Y6.39%
EPS Next 5Y6.49%
Revenue Next Year-0.43%
Revenue Next 2Y1.5%
Revenue Next 3Y2.11%
Revenue Next 5Y3.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.84 indicates a correct valuation of BN.
Based on the Price/Earnings ratio, BN is valued a bit cheaper than 62.07% of the companies in the same industry.
When comparing the Price/Earnings ratio of BN to the average of the S&P500 Index (25.20), we can say BN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 16.25, the valuation of BN can be described as correct.
BN's Price/Forward Earnings ratio is in line with the industry average.
BN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.60.
Industry RankSector Rank
PE 16.84
Fwd PE 16.25

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, BN is valued a bit cheaper than 67.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 14.74
EV/EBITDA 8.16

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)4.66
PEG (5Y)N/A
EPS Next 2Y5.68%
EPS Next 3Y6.39%

4

5. Dividend

5.1 Amount

BN has a Yearly Dividend Yield of 3.56%.
Compared to an average industry Dividend Yield of 3.26, BN pays a bit more dividend than its industry peers.
BN's Dividend Yield is a higher than the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.56%

5.2 History

On average, the dividend of BN grows each year by 24.27%, which is quite nice.
Dividend Growth(5Y)24.27%
Div Incr Years2
Div Non Decr Years3

5.3 Sustainability

146.51% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
BN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP146.51%
EPS Next 2Y5.68%
EPS Next 3Y6.39%

DANONE

EPA:BN (4/23/2024, 7:00:00 PM)

59.6

-0.34 (-0.57%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.26B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.56%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 16.84
Fwd PE 16.25
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.96%
ROE 5.4%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.6%
PM (TTM) 3.16%
GM 47.37%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.93
Quick Ratio 0.76
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)3.21%
EPS 3Y1.96%
EPS 5Y
EPS growth Q2Q
EPS Next Y3.61%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.15%
Revenue growth 3Y5.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y